首页> 外文期刊>PLoS Computational Biology >Improving virtual screening of G protein-coupled receptors via ligand-directed modeling
【24h】

Improving virtual screening of G protein-coupled receptors via ligand-directed modeling

机译:通过配体定向建模改善对G蛋白偶联受体的虚拟筛选

获取原文
获取外文期刊封面目录资料

摘要

G protein-coupled receptors (GPCRs) play crucial roles in cell physiology and pathophysiology. There is increasing interest in using structural information for virtual screening (VS) of libraries and for structure-based drug design to identify novel agonist or antagonist leads. However, the sparse availability of experimentally determined GPCR/ligand complex structures with diverse ligands impedes the application of structure-based drug design (SBDD) programs directed to identifying new molecules with a select pharmacology. In this study, we apply ligand-directed modeling (LDM) to available GPCR X-ray structures to improve VS performance and selectivity towards molecules of specific pharmacological profile. The described method refines a GPCR binding pocket conformation using a single known ligand for that GPCR. The LDM method is a computationally efficient, iterative workflow consisting of protein sampling and ligand docking. We developed an extensive benchmark comparing LDM-refined binding pockets to GPCR X-ray crystal structures across seven different GPCRs bound to a range of ligands of different chemotypes and pharmacological profiles. LDM-refined models showed improvement in VS performance over origin X-ray crystal structures in 21 out of 24 cases. In all cases, the LDM-refined models had superior performance in enriching for the chemotype of the refinement ligand. This likely contributes to the LDM success in all cases of inhibitor-bound to agonist-bound binding pocket refinement, a key task for GPCR SBDD programs. Indeed, agonist ligands are required for a plethora of GPCRs for therapeutic intervention, however GPCR X-ray structures are mostly restricted to their inactive inhibitor-bound state.
机译:G蛋白偶联受体(GPCR)在细胞生理和病理生理中起着至关重要的作用。使用结构信息进行文库的虚拟筛选(VS)以及基于结构的药物设计来识别新型激动剂或拮抗剂前导的兴趣日益浓厚。但是,实验确定的具有各种配体的GPCR /配体复杂结构的稀疏可用性阻碍了基于结构的药物设计(SBDD)程序的应用,该程序旨在通过选定的药理学鉴定新分子。在这项研究中,我们将配体导向模型(LDM)应用到可用的GPCR X射线结构中,以改善VS性能和对特定药理学特征分子的选择性。所描述的方法使用单个已知的GPCR配体来完善GPCR结合口袋构象。 LDM方法是一种计算有效的迭代工作流程,由蛋白质采样和配体对接组成。我们开发了一个广泛的基准,将跨越七种不同GPCR的LDM精制结合袋与GPCR X射线晶体结构进行了比较,这些GPCR与一系列不同化学型和药理学特征的配体结合。 LDM改进的模型在24例病例中有21例显示出相对于原始X射线晶体结构的VS性能有所改善。在所有情况下,LDM精炼模型在精炼配体的化学型富集方面均具有卓越的性能。在抑制剂结合至激动剂结合的结合口袋精制的所有情况下,这很可能有助于LDM成功,这是GPCR SBDD程序的关键任务。实际上,大量GPCR需要激动剂配体来进行治疗干预,但是GPCR X射线结构大多限于其无活性的抑制剂结合状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号